Forest Labs wins U.S. antitrust approval to buy Furiex
WASHINGTON May 30 (Reuters) - Forest Laboratories Inc has won U.S. antitrust approval to buy Furiex Pharmaceuticals Inc, the Federal Trade Commission said on Friday.
Forest had said on April 28 that it would buy Furiex for up to $1.46 billion, adding a promising treatment for irritable bowel syndrome to its gastrointestinal drugs portfolio.
The deal was on a list of approved transactions that the FTC releases several times a week. (Reporting by Diane Bartz)
Trending On Reuters
We are living longer but not creating financial plans to keep pace. Advisers give tips on how to make sure you don’t outlive your money. Video